0001209191-23-052349.txt : 20231006 0001209191-23-052349.hdr.sgml : 20231006 20231006165840 ACCESSION NUMBER: 0001209191-23-052349 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231004 FILED AS OF DATE: 20231006 DATE AS OF CHANGE: 20231006 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Turner Christopher Durant CENTRAL INDEX KEY: 0001862146 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40671 FILM NUMBER: 231314783 MAIL ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nuvalent, Inc. CENTRAL INDEX KEY: 0001861560 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 508-446-2272 MAIL ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-10-04 0 0001861560 Nuvalent, Inc. NUVL 0001862146 Turner Christopher Durant C/O NUVALENT, INC. ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 0 1 0 0 Chief Medical Officer 1 Class A Common Stock 2023-10-04 4 M 0 7995 6.89 A 22508 D Class A Common Stock 2023-10-04 4 S 0 2665 51.32 D 19843 D Class A Common Stock 2023-10-04 4 S 0 2265 53.70 D 17578 D Class A Common Stock 2023-10-04 4 S 0 600 54.32 D 16978 D Class A Common Stock 2023-10-04 4 S 0 500 55.84 D 16478 D Class A Common Stock 2023-10-04 4 S 0 500 57.18 D 15978 D Class A Common Stock 2023-10-04 4 S 0 1465 57.70 D 14513 D Stock Option (Right to Buy) 6.89 2023-10-04 4 M 0 7995 0.00 D 2031-04-29 Class A Common Stock 7995 303105 D These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 21, 2021. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.15 to $51.49, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (7) of this Form 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.01 to $54.00, inclusive. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.01 to $54.96, inclusive. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.44 to $56.00, inclusive. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.49 to $57.40, inclusive. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.54 to $58.00, inclusive. The shares underlying this option vest as follows: 25% of the shares vested on March 22, 2022, and the remainder have vested or shall vest over the next three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date. /s/ Deborah Ann Miller, attorney-in-fact 2023-10-06